Pioneering Molecular Immune Cell Quantification

Epimune’s goal is to revolutionize diagnosis and monitoring of patients with disorders of the immune system 

 

Using epigenetics, Epimune develops & commercializes molecular diagnostic tests for immune cell quantification from a drop of blood


News

14 Apr 2021

2 abstracts by Epimune's collaborators selected for presentation at the CIS 2021 Virtual Annual Meeting


For a Spanish version of this video please click here!